You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 68 No. 3, September 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (55)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mannitol Infusion to Reduce Intraocular Pressure

DANIEL I. WEISS, M.D.; ROBERT N. SHAFFER, M.D.; BURTON L. WISE, M.D.

Arch Ophthalmol. 1962;68(3):341-347.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1904, Cantonnet recommended les substances osmotiques (sodium chloride, lactose) in the treatment of glaucoma.1 Since then a number of osmotic agents have been used, with more or less success, to lower both cerebrospinal fluid pressure and intraocular pressure.2-4 Recently, intravenous hypertonic urea has been effectively used.5,6

Mannitol, a 6-carbon hexahydric alcohol, has been employed fairly extensively as an osmotic diuretic.7,8 Recent experimental and clinical studies have demonstrated that hypertonic mannitol solutions are effective in lowering cerebrospinal fluid pressure and decreasing brain mass.9,12,20 Mannitol is stable in solution, inert, and nontoxic, and its distribution is limited to the extracellular fluid compartment.8-10 These facts indicated that hypertonic mannitol might be an excellent agent for the reduction of intraocular pressure.

Methods and Materials

Ten consecutive patients who received mannitol infusions are included in this study. The group is comprised of 2 patients from the neurosurgical service . . . [Full Text PDF of this Article]


Author Affiliations

New York; San Francisco

USPHS Special Fellow in Ophthalmology (Dr. Weiss).; From the Departments of Ophthalmology and Neurological Surgery, University of California School of Medicine.


Footnotes

Submitted for publication March 2, 1962.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.